Subcutaneous immunoglobulin (16 or 20%) therapy in obese patients with primary immunodeficiency: a retrospective analysis of administration by infusion pump or subcutaneous rapid push

Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy

(2012) J. S. Orange et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Prevalence of Obesity and Trends in Body Mass Index Among US Children and Adolescents, 1999-2010

(2012) Cynthia L. Ogden et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010

(2012) Katherine M. Flegal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies

(2011) M. Borte et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IgG replacement therapy, no size fits all

(2011) Francisco A. Bonilla   CLINICAL IMMUNOLOGY

Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies

(2011) Melvin Berger et al.   CLINICAL IMMUNOLOGY

Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy

(2011) S. Jolles et al.   CLINICAL IMMUNOLOGY

Improved Quality of Life, Immunoglobulin G Levels, and Infection Rates in Patients with Primary Immunodeficiency Diseases during Self-Treatment with Subcutaneous Immunoglobulin G

(2011) Melvin Berger et al.   SOUTHERN MEDICAL JOURNAL

Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies

(2010) Jordan S. Orange et al.   CLINICAL IMMUNOLOGY

Subcutaneous Immunoglobulin Therapy by Rapid Push is Preferred to Infusion by Pump: A Retrospective Analysis

(2010) Ralph Shapiro   JOURNAL OF CLINICAL IMMUNOLOGY

Pharmacokinetics of Immunoglobulin Administered via Intravenous or Subcutaneous Routes

(2008) Francisco A. Bonilla   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Subcutaneous Administration of IgG

(2008) Melvin Berger   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Biologic IgG level in primary immunodeficiency disease: The IgG level that protects against recurrent infection

(2008) Vincent R. Bonagura et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY